Dynamic Scaffold Versus Lichtenstein Open Hernioplasty.
NCT ID: NCT05706662
Last Updated: 2023-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
188 participants
INTERVENTIONAL
2018-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ProFlor
patients underwent to inguinal hernia repair with use of ProFlor dynamic scaffold
inguinal hernia repair with mesh
inguinal hernia repair with mesh
Lichtenstein
patients underwent to Lichtenstein inguinal hernia repair
inguinal hernia repair with mesh
inguinal hernia repair with mesh
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inguinal hernia repair with mesh
inguinal hernia repair with mesh
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Incarcerated inguinal hernia
* Hernia not in the inguinal area
* Signs of obvious local or systemic infection
* ASA score \> 4
* Presenting with unstable angina or NYHA class of IV
* Pregnant
* Active drug user
* Immunosuppression, chemotherapy
* Chronic renal insufficiency
* Abdominal ascites
* Infection in area of the surgical field
* BMI \>35
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Palermo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Antonino Agrusa
full professor of surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Palermo
Palermo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DySLOH
Identifier Type: -
Identifier Source: org_study_id